Here are four things to know about the payment:
- Radioisotopes, specifically Mo-99 and Tc-99m, are crucial for the detection of disease in medical imaging and radiopharmaceuticals. Tc‑99m and its source material, Mo-99, are historically derived from reactors outside the U.S.
- A $10-per-dose add-on payment for radiopharmaceuticals that use Tc-99m derived from domestically produced Mo-99 will begin Jan. 1, 2026.
- CMS said paying providers that use domestically produced Tc-99m radiopharmaceuticals will offset anticipated higher costs.
- “These artificially low, foreign government-subsidized prices have created a disincentive for domestic investments in Mo-99 production infrastructure and a barrier to entry for new producers,” CMS said in a Nov. 1 news release.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
